155 related articles for article (PubMed ID: 9600348)
1. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
2. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity.
Nilakantan V; Spear BT; Glauert HP
Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
Li Y; Leung LK; Glauert HP; Spear BT
Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
[TBL] [Abstract][Full Text] [Related]
4. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
[TBL] [Abstract][Full Text] [Related]
5. Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.
Li Y; Glauert HP; Spear BT
Biochem Pharmacol; 2000 Feb; 59(4):427-34. PubMed ID: 10644051
[TBL] [Abstract][Full Text] [Related]
6. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice.
Budroe JD; Umemura T; Angeloff K; Williams GM
Toxicol Appl Pharmacol; 1992 Apr; 113(2):192-8. PubMed ID: 1561628
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
Rao MS; Subbarao V
Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
[TBL] [Abstract][Full Text] [Related]
9. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
10. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB.
Li Y; Tharappel JC; Cooper S; Glenn M; Glauert HP; Spear BT
DNA Cell Biol; 2000 Feb; 19(2):113-20. PubMed ID: 10701777
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes.
Hong JT; Glauert HP
Toxicology; 1998 Nov; 131(2-3):99-107. PubMed ID: 9928625
[TBL] [Abstract][Full Text] [Related]
12. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
13. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
[TBL] [Abstract][Full Text] [Related]
14. Role of the p50 subunit of NF-kappaB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate.
Calfee-Mason KG; Lee EY; Spear BT; Glauert HP
Food Chem Toxicol; 2008 Jun; 46(6):2062-73. PubMed ID: 18336980
[TBL] [Abstract][Full Text] [Related]
15. Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate.
Yang JH; Kostecki PT; Calabrese EJ; Baldwin LA
Toxicol Appl Pharmacol; 1990 Jul; 104(3):476-82. PubMed ID: 2385837
[TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats.
Leung LK; Glauert HP
Toxicology; 1997 Nov; 123(1-2):101-9. PubMed ID: 9347925
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
18. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
19. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
Hong JT; Glauert HP
J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate.
Tharappel JC; Nalca A; Owens AB; Ghabrial L; Konz EC; Glauert HP; Spear BT
Toxicol Sci; 2003 Oct; 75(2):300-8. PubMed ID: 12883078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
